Transducción de señales: Visión general

When an extracellular ligand or drug binds a receptor, it changes the receptor's conformation to activate it. This activated receptor then transmits and amplifies the signal through different pathways depending on receptor type, initiating a cascade of molecular reactions that ultimately produces a cellular response.

GPCRs associate with heterotrimeric G proteins to interact with effectors and produce second messengers like cyclic AMP. These second messengers carry the signal to target proteins throughout the cell, allowing the transducer mechanism G protein-coupled receptors to amplify and relay the initial signal from the cell surface.

Ligand-gated ion channels facilitate ion movement across the cell membrane, changing the membrane potential and mediating cellular activities like neurotransmission and muscle contraction. Various drugs bind at the ligand binding site, allosteric site, or channel pore to regulate the opening and closing of the ligand-gated ion channel receptor gating mechanism.

Enzyme-linked receptors have intracellular kinase domains that phosphorylate multiple downstream effectors to modulate gene expression. Unlike GPCRs that use second messengers, these receptors directly activate a phosphorylation cascade, making them unique transmembrane proteins involved in cell proliferation, growth, differentiation, and immune responses.

Lipophilic drugs and steroids cross the cell bilayer to bind cytosolic nuclear receptors. The drug-receptor complexes then translocate to the nucleus and regulate gene transcription, allowing these ligand-activated transcription factors to control genes involved in reproduction and metabolic pathways throughout the organism.

Signal transduction involves reception, where a ligand binds a membrane receptor; transduction, where the receptor sends signals to intracellular messengers; and response, where those messengers convert the message into a cellular action. This three-step process allows cells to respond appropriately to chemical signals like hormones and neurotransmitters.

Different receptor types activate distinct signaling pathways and produce different cellular responses. By targeting specific receptors involved in particular diseases, pharmaceutical companies can design drugs with different structural and chemical properties to modulate the appropriate signaling pathway, maximizing therapeutic benefit while minimizing unwanted effects.